23andMe to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Oct. 12, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq:ME) (“23andMe”), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that management will be participating in investor presentations at the following conferences:
Related news for (ME)
- CME Group Inc. Announces Third-Quarter 2025 Financial Results
- Don’t Miss Out: MoBot’s Latest Stock Updates 10/20/25 10:00 AM
- Breaking News: MoBot’s Latest Update as of 10/20/25 09:00 AM
- Today’s Top Performers: MoBot’s Market Review 10/17/25 07:00 PM
- MoBot alert highlights: NASDAQ: VRME, NASDAQ: ATAI, NASDAQ: STKE, NASDAQ: FGI, NASDAQ: LNKS (10/17/25 06:00 PM)
